Clinical Trial Update: Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erlotinib for brain metastases in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Non-Small Cell Lung Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN